Prima Biomed Ltd. (PBMD)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.90+0.02 (+2.84%)
At close: 4:00 PM EDT
People also watch:
AVEOCEREOHGIVLTCISR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.88
Prev Close0.88
Bid0.72 x 300
Ask0.94 x 200
Day's Range0.88 - 0.90
52wk Range0.72 - 1.54
1y Target EstN/A
Market Cap59.6M
P/E Ratio (ttm)-1.44
Beta0.72
Volume119,737
Avg Vol (3m)90,660
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Prima BioMed Ltd. :PBMD-US: Earnings Analysis: 2016 By the Numbers : September 13, 2016
    Capital Cube16 days ago

    Prima BioMed Ltd. :PBMD-US: Earnings Analysis: 2016 By the Numbers : September 13, 2016

    Categories: Yahoo Finance Get free summary analysis Prima BioMed Ltd. reports financial results for the year ended June 30, 2016. We analyze the earnings along side the following peers of Prima BioMed Ltd. – Radius Health Inc, HTG Molecular Diagnostics, Inc., FibroGen, Inc. and Illumina, Inc. (RDUS-US, HTGM-US, FGEN-US and ILMN-US) that have also reported for this period. ... Read more (Read more...)

  • Marketwiredlast month

    European Patent Grants for IMP731 Antibody

    Prima BioMed Ltd announces the granting of patent number 2142210 entitled "Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune ...

  • Marketwiredlast month

    Prima BioMed Ltd: Operational Update

    Prima BioMed Ltd , has provided an update on the Company's cash position and the recruitment progress in its two active clinical trials in IMP321.